Drug Co. Reaches $17M Deal In False Claims Act Suit
The U.S. Department of Justice has reached a $17 million settlement with a drug compounding service accused of submitting false claims to Medicare and other governmental health-care programs over the manufacture...To view the full article, register now.
Already a subscriber? Click here to view full article